We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Hears Arguments Over ‘Skinny Labeling’
Appeals Court Hears Arguments Over ‘Skinny Labeling’
As Teva Pharmaceuticals tries to convince the full U.S. Court of Appeals for the Federal Circuit to reconsider its earlier judgment that it has to pay $235.5 million in damages to GlaxoSmithKline (GSK) for patent infringement, oral arguments this week left it unclear whether the final decision will be any different.